You have picked up this pamphlet because you are concerned with the question whether you would like to take advantage of the direct molecular genetic test for Huntington's Disease (HD). This test has been available since 1993. Results of this test provide a view into a person's future. They are not a diagnosis of a manifest disease, but provide the information that he (1) who receives a medically positive result (2) carries a mutated gene for HD and if he lives long enough will develop the disease. Alternatively, given a negative result HD will not develop (3).
Decisions which affect a person's future should only be made after careful
consideration. The advantages and disadvantages of the consequences of such
decision to undergo the test should be weighed carefully against each other.
Only after you fully understand the consequences of the test should you decide
for or against it. This pamphlet will try to summarize experiences gathered in the
last three years. It groups the many-layered questions concerning the test into
individual problem areas - without claiming to be complete.
It should serve as a guide and help in reaching a decision and most importantly
stimulate thought. That is why we call it "Food for Thought."
I thank my colleagues from the Deutsche Huntington-Hilfe e.V., (DHH. Help for
Huntington's in Germany) individuals known to me who underwent testing who
contributed their experience, also members of the Huntington's Society in Germany who gave me "Food for Thought" and Ms. Helga Ahrens who kindly translated it.
Christiane Lohkamp
Vice President of the DHH e.V.,
Vice President of the International Huntington Association (IHA)
Stuttgart, May 25, 1996
1. General Information about the Predictive
Molecular Genetic Test.
This test predicts with near 100% certainty (4) whether or not an individual carries the genetic mutation that leads to the development of HD. The test provides indisputable results and can therefore change completely the life of a person that undergoes the test. A positive test result does not imply that HD is manifest. The information provided by the test results is limited.
It cannot answer questions such as:
- When will a gene carrier develop the disease?
- How will the disease progress?